Pharmacoequity refers to equity in access to pharmacotherapy for all patients and is an
especially large barrier to biologic agents in patients with allergic diseases. Value-based …

Objective Shared decision-making is increasingly used in food allergy. We review its use in
the areas of prevention, diagnosis and management. Data Sources PubMed and online …

Objective Allergen immunotherapy (AIT) is the therapeutic exposure to an allergen or
allergens selected by clinical assessment and allergy testing to decrease allergic symptoms …

Allergic disease management for adolescents and young adults requires consideration of
unique psychosocial challenges and opportunities. Erik Erikson's model for the Stages of …

Allergist-immunologists use serologic peanut allergy testing to maximize test sensitivity and
specificity while minimizing cost and inconvenience. Recent advances toward this goal …

Abstract Background: Being stung by Hymenoptera species can cause life-threatening
anaphylaxis. Although venom immunotherapy (VIT) seems to be the most effective …

In this review, we compare different refractory anaphylaxis (RA) management guidelines
focusing on cardiovascular involvement and best practice recommendations, discuss …

CIndU is a hard-to-treat disease that highly impairs quality of life (QoL) of affected patients.
Provocation tests allow to diagnose CIndU subtypes. The only licensed and recommended …

Epinephrine autoinjectors (EAIs) are used for the treatment of severe allergic reactions in a
community setting; however, their utility is limited by low prescription fulfillment rates, failure …

For clinicians involved in improving healthcare for patients with allergic and immunologic
conditions, advocacy on a broader level through public outreach is key to advancing value …